AdWiki Webring Site
| SELECT YOUR LANGUAGE:
ar  |
id  |
bg  |
ca  |
ceb  |
cs  |
da  |
de  |
et  |
en  /  /  |
es  |
eo  |
fr  |
gr  |
he  |
hr  |
it  |
ko  |
lt  |
hu  |
nl  |
ja  |
no  |
pl  |
pt  |
ru  |
ro  |
sk  |
sl  |
sr  |
fi  |
sv  |
te  |
tr  |
uk  |
zh 
Inolimomab
From Wikipedia, the free encyclopedia
Inolimomab is a mouse monoclonal antibody which it's used as an immunosuppressive drug.
Its target is the interleukin-2 receptor.[1]
[edit] References
|
Immunomodulators – Immunosuppressants – Immunosuppressive drugs (L04) |
|
Intracellular
(signal initiation) |
|
|
| Extracellular |
|
|
|
|
|
Serum target
(noncellular)
|
|
|
|
Cellular target
|
CD3 ( Muromonab-CD3, Otelixizumab, Teplizumab, Visilizumab) · CD4 ( Clenoliximab, Keliximab, Zanolimumab) · CD11a ( Efalizumab) · CD18 ( Erlizumab) · CD20 ( Ocrelizumab, Pascolizumab) · CD23 ( Lumiliximab) · CD40 ( Teneliximab, Toralizumab) · CD62L/L-selectin ( Aselizumab) · CD80 ( Galiximab) · CD147/Basigin ( Gavilimomab, Ziralimumab) · CD154 ( Ruplizumab)
BLyS (Belimumab) · CTLA-4 (Ipilimumab, Tremelimumab) · CAT (Bertilimumab, Lerdelimumab, Metelimumab) · Integrin (Natalizumab) · Interleukin-6 receptor (Tocilizumab) · LFA-1 (Odulimomab)
IL-2 receptor/CD25 (Basiliximab, Daclizumab, Inolimomab)
T-lymphocyte ( Zolimomab aritox)
|
|
|
Unsorted
|
Atlizumab, Atorolimumab, Cedelizumab, Dorlimomab aritox, Dorlixizumab, Fontolizumab, Gantenerumab, Gomiliximab, Lebrilizumab, Maslimomab, Morolimumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Vapaliximab, Vepalimomab
|
|
|
|
|
|
|
|
|
|
|
|
|
Intracellular
(signal reception) |
|
|
|
Mouse monoclonal antibodies ("-o-") |
|
| "-govo-" (ovarian tumor) |
|
|
| "-limo-" (immune system) |
Afelimomab, Dorlimomab aritox, Elsilimomab, Enlimomab pegol, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox
|
|
| "-tumo-" (miscellaneous tumor) |
Altumomab, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, Detumomab, Epitumomab cituxetan, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab pendetide, Taplitumomab paptox, Tenatumomab, Tositumomab, 3F8
|
|
| "-leso-" (infectious lesions) |
|
|
| "-ciro-" (cardiovascular) |
|
|
| "-pro-" (prostate tumor) |
|
|
| "-baco-" (bacterial) |
|
|
| "-colo-" (colonic tumor) |
|
|
| §Withdrawn |
|
Change language: All |
Arabic |
Indonesian |
Bulgarian |
Catalan |
Cebuano |
Czech |
Danish |
German |
Estonian |
English / / |
Spanish |
Esperanto |
French |
Greek |
Hebrew |
Croatian |
Italian |
Korean |
Lithuanian |
Hungarian |
Flemish / Dutch |
Japanese |
Norwegian |
Polish |
Portugues |
Russian |
Romanian |
Slovakian |
Slovenian |
Serbian |
Suomi / Finish |
Swedish |
Iranian |
Turkish |
Ukrainian |
Chinese
MORE LINKS...
Autorem skryptu AdWiki v0.62 (2007) jest husky83
Licencję na skrypt dla strony DAWAJ.INFO posiada dzankes
Wikipedia® jest zarejestrowanym znakiem towarowym Wikimedia Foundation |
